Urgent.News

What's breaking now, across thousands of outlets.

World

KBO to hand out MVP, top rookie awards Nov. 26

The top baseball league announced Friday it will hold its annual awards ceremony next week in Seoul, to be highlighted by the regular-season MVP award and the top rookie prize. The Korea Baseball Organization (KBO) said the annual KBO Awards ceremony will take place at 2 p.m. next Thursday at Lotte Hotel World in Seoul. The KBO announced 14 candidates for the MVP award on Oct. 13, with leaders of…

KBO to hand out MVP, top rookie awards Nov. 26

The Korea Baseball Organization (KBO) announced Friday that it will hold its annual awards ceremony next week in Seoul, featuring the regular-season Most Valuable Player (MVP) award and the top rookie prize. The KBO Awards ceremony is scheduled for 2 p.m. next Thursday at Lotte Hotel World in Seoul.

On October 13, the KBO released 14 candidates for the MVP award. Those leading in pitching and hitting categories automatically received nominations. Nine players earned Rookie of the Year nominations. To qualify as a rookie, players couldn't have reached 30 innings pitched or 60 plate appearances over the past five years, with exceptions for those who had played professionally overseas before joining the KBO.

Voting by members of the Korea Baseball Writers Association to determine the award winners was completed after the regular season ended on October 12. Kim Do-yeong from the Kia Tigers is considered one of the front-runners for the MVP award. Kim, who won the 2024 MVP title, led the KBO with a career-high 45 home runs and a .647 slugging percentage. He also ranked in the top five for runs scored and RBIs.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at koreatimes.co.kr →

More in World

German Court Overturns Keytruda SC Sales Ban, Opening Door to European Expansion

The path to market entry in Germany, Europe’s largest pharmaceutical market, has opened for Keytruda SC, the subcutaneous formulation of the immuno-oncology drug developed by U.S.-based Merck (MSD)…

  • German court overturns ban on Keytruda SC sales, allowing European expansion.
  • Merck wins patent disputes in Germany and U.S., clearing path for drug's entry.
  • Keytruda SC's subcutaneous formulation reduces treatment time to one to two minutes.

More from Friday 20 November →